Cargando…
Potential of blood-based biomarker approaches in endometrium and breast cancer: a case-control comparison study
PURPOSE: Endometrial carcinoma is the second most common gynecological malignancy. Until today lacking a screening tool. A blood-based biomarker could help address this need. METHODS: The expression levels of 30 acylcarnitines, 18 amino acids, 6 miRNAs, and 7 DNA methylation sites were measured in b...
Autores principales: | Schuhn, Anne, Tobar, Tania Witte, Gahlawat, Aoife Ward, Hauke, Jana, Baumann, Lukas, Okun, Jürgen G., Nees, Juliane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519681/ https://www.ncbi.nlm.nih.gov/pubmed/35284957 http://dx.doi.org/10.1007/s00404-022-06482-8 |
Ejemplares similares
-
How previous treatment changes the metabolomic profile in patients with metastatic breast cancer
por: Nees, Juliane, et al.
Publicado: (2022) -
Membrane expression of TRAIL receptors DR4, DR5, DcR1 and DcR2 in the normal endometrium, atypical endometrial hyperplasia and endometrioid adenocarcinoma: a tissue microarray study
por: Gottwald, Leszek, et al.
Publicado: (2013) -
Endometrial hyperplasia as a risk factor of endometrial cancer
por: Nees, Lisa K., et al.
Publicado: (2022) -
A novel circulating miRNA panel for non-invasive ovarian cancer diagnosis and prognosis
por: Gahlawat, Aoife Ward, et al.
Publicado: (2022) -
Total circulating microRNA level as an independent prognostic marker for risk stratification in breast cancer
por: Gahlawat, Aoife Ward, et al.
Publicado: (2022)